P. Shi

发表

Effect of sorafenib maintenance on Epstein-Barr virus and cytomegalovirus infections in patients with FLT3-ITD AML undergoing allogeneic hematopoietic stem cell transplantation: a secondary analysis of a randomized clinical trial

Yu Wang, S. Tu, Yan Chen, 2022, BMC Medicine.

Metagenomic next-generation sequencing for identifying pathogens in central nervous system complications after allogeneic hematopoietic stem cell transplantation

Zhi-xiang Wang, F. Huang, L. Xuan, 2021, Bone Marrow Transplantation.

A phase 2 study of sorafenib combined with conventional therapies in refractory central nervous system leukemia

D. Nie, Zhi-xiang Wang, F. Huang, 2022, Cancer.

Association Between Measurable Residual Disease in Patients With Intermediate-Risk Acute Myeloid Leukemia and First Remission, Treatment, and Outcomes

Shunqing Wang, Yu Wang, Li-ping Ma, 2021, JAMA network open.

Comparison of Two Strategies for Prophylactic Donor Lymphocyte Infusion in Patients With Refractory/Relapsed Acute Leukemia

D. Nie, Zu-jun Jiang, Zhi-xiang Wang, 2021, Frontiers in Oncology.

Haplo-peripheral blood stem cell plus cord blood grafts for hematologic malignancies might lead to lower relapse compared with haplo-peripheral blood stem cell plus bone marrow grafts.

Zhi-xiang Wang, F. Huang, L. Xuan, 2022, Transplantation and cellular therapy.

Dynamic assessment of measurable residual disease in favorable-risk acute myeloid leukemia in first remission, treatment, and outcomes

Yu Wang, D. Nie, Caixia Wang, 2021, Blood Cancer Journal.

Haploidentical Related Donor versus Matched Sibling Donor Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndrome Aged Over 50 Years: A Single-Center Retrospective Study.

F. Huang, L. Xuan, Z. Fan, 2019 .

The effect of granulocyte-colony stimulating factor, decitabine, and busulfan-cyclophosphamide versus busulfan-cyclophosphamide conditioning on relapse in patients with myelodysplastic syndrome or secondary acute myeloid leukaemia evolving from myelodysplastic syndrome undergoing allogeneic haematop

Yu Wang, Jie-yu Ye, D. Nie, 2023, The Lancet. Haematology.

Cidofovir, a choice for salvage treatment of cytomegalovirus infection in patients with haploidentical hematopoietic stem cell transplantation

Zhi-xiang Wang, F. Huang, L. Xuan, 2021, Transplant infectious disease : an official journal of the Transplantation Society.

Upfront transplantation may have better outcomes than pretransplant cytoreductive therapy for treating patients with MDS‐EB‐1 or MDS‐EB‐2

Zhi-xiang Wang, F. Huang, L. Xuan, 2021, International journal of cancer.

Haploidentical donor transplant is associated with secondary poor graft function after allogeneic stem cell transplantation: A single‐center retrospective study

Zhi-xiang Wang, F. Huang, L. Xuan, 2021, Cancer medicine.

Graft-vs-Host Disease-Induced Hyperthyroidism in a Recipient of Allogeneic Hematopoietic Stem Cell Transplantation: A Case Report.

Jie-yu Ye, F. Huang, L. Xuan, 2020, Transplantation proceedings.

Busulfan Plus Cyclophosphamide Versus Total Body Irradiation Plus Cyclophosphamide for Adults Acute B Lymphoblastic Leukemia: An Open-Label, Multicenter, Phase III Trial

Shunqing Wang, Shuangfeng Xie, H. Qu, 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Sorafenib maintenance in patients with FLT3-ITD acute myeloid leukaemia undergoing allogeneic haematopoietic stem-cell transplantation: an open-label, multicentre, randomised phase 3 trial.

S. Tu, Yu Wang, Yan Chen, 2020, The Lancet. Oncology.

Haploidentical transplantation has a superior graft-versus-leukemia effect than HLA-matched sibling transplantation for Ph– high-risk B-cell acute lymphoblastic leukemia

Shunqing Wang, Yu Wang, Xiao-jun Huang, 2021, Chinese medical journal.

Allogeneic hematopoietic stem cell transplantation overcomes the poor prognosis in MLL-rearranged solid tumor therapy related-acute myeloid leukemia.

Z. Fan, F. Huang, Jing Sun, 2020, American journal of cancer research.

IL-6 trans-signaling promotes the expansion and anti-tumor activity of CAR T cells

Yangqiu Li, Suna Wang, D. Pei, 2020, Leukemia.

Venetoclax Combined with Azacitidine and Homoharringtonine in Relapsed/Refractory AML: A Multicenter, Phase 2 Trial

Jie Xiao, Xuejie Jiang, F. Huang, 2023, Journal of Hematology & Oncology.

Idarubicin plus BuCy versus BuCy conditioning regimens for intermediate‐risk acute myeloid leukemia in first complete remission undergoing auto‐HSCT: An open‐label, multicenter, randomized phase 3 trial

Zhi-xiang Wang, F. Huang, L. Xuan, 2023, American journal of hematology.

Cidofovir, a Choice for Salvage Treatment of CMV Infection in the Patients with Haploidentical Hematopoitic Stem Cell Transplantation

F. Huang, Z. Fan, Jing Sun, 2020 .

Sorafenib maintenance after allogeneic haemopoietic stem-cell transplantation in patients with FLT3-ITD acute myeloid leukaemia: long-term follow-up of an open-label, multicentre, randomised, phase 3 trial.

Yu Wang, S. Tu, Yan Chen, 2023, The Lancet. Haematology.